Navigation Links
Breast Imaging Company, TechniScan, Signs Manufacturing Agreement With Texas Company
Date:2/24/2011

SALT LAKE CITY, Feb. 24, 2011 /PRNewswire/ -- TechniScan (OTC Bulletin Board: TSNI), a medical device company engaged in the development and commercialization of an automated 3D breast ultrasound imaging system, announced today that it has signed agreements for manufacturing and use of trademarks with Austin, Texas-based Womens3D.

These agreements follow a product development agreement signed between the two companies in January 2011 in which they agreed to jointly develop a specialized version of TechniScan's Warm Bath Ultrasound (WBU) system specifically for Womens3D target market of women's specific health practices such as OB/GYN and general practice offices.

Under the terms of the manufacturing agreement, TechniScan will be the exclusive manufacturer and supplier of the product(s) and Womens3D will receive a license to sell the product to its target market. The license becomes exclusive upon certain conditions being met, including payment of at least $1.5 million to TechniScan in connection with the initial design and development of the product. Womens3D has also committed to purchase at least $10 million of TechniScan's products during the 36 months following FDA approval.

In addition to the manufacturing and trademark agreements, TechniScan receives shares of Womens3D common stock equal to 20 percent of the current capitalization of Womens3D.

"TechniScan is energized by our new partnership with Womens3D. We are looking forward to collaborating on the development and manufacturing of a WBU imaging system that addresses the unique needs of their target market. The partnership will potentially open new markets for our equipment and add an experienced medical imaging partner to our development efforts," said Dave Robinson, chief executive officer of TechniScan. 

Womens3D's Chief Medical Officer and Research Scientist and Imagin
'/>"/>

SOURCE TechniScan
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
6. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
7. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
8. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
9. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
10. Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research
11. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... LUNGevity Foundation, the nation,s leading lung ... (FDA) approval of Bristol Myers Squibb,s new immunotherapy ... add another critical new treatment option to fight ... patient,s own immune system to fight cancerous cells. ... patients with squamous cell lung cancer, a population ...
(Date:3/5/2015)... , March 5, 2015 Soligenix, Inc. ... biopharmaceutical company committed to developing products that address unmet ... biodefense, announced today that its President and Chief Executive ... a corporate presentation at the 27 th Annual ... , on Tuesday, March 10, 2015 at 1:00 PM ...
(Date:3/5/2015)... , March 5, 2015 ... System Market by Product (Systems and Disposables), by Type ... Labs , Home and Ambulatory Sites) - Analysis & ... Systems Market is expected to reach $1,107.4 Million by ... to grow at a CAGR of 4.5% during the ...
Breaking Medicine Technology:LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3Soligenix to Present at the 27th Annual ROTH Conference 2Soligenix to Present at the 27th Annual ROTH Conference 3Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 3Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 4
... Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: ... Cephalon, Inc. (NASDAQ: CEPH): In a letter ... stated that it "is presently undertaking a review of ... is focused on maximizing Cephalon shareholder value."  We know ...
... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced ... to discuss first quarter 2011 financial results, as well as ... at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time; 2:00 ... ended March 31, 2011 will be released earlier that day. ...
Cached Medicine Technology:Valeant Pharmaceuticals Responds to Cephalon Board's Letter 2Valeant Pharmaceuticals Responds to Cephalon Board's Letter 3Valeant Pharmaceuticals Responds to Cephalon Board's Letter 4Onyx Pharmaceuticals Announces First Quarter 2011 Financial Results Teleconference and Webcast 2
(Date:3/6/2015)... 2015 Magellan Rx Management’s 2014 Medical ... for key trends and statistics on one of the ... from Magellan Rx Management will discuss key findings from ... Hidden Specialty Drug Spend,” a complimentary March 19 webinar, ... Specialty drug spend makes up more than a quarter ...
(Date:3/6/2015)... 06, 2015 The Gluten-Free Certification ... Association, is pleased to announce that Dufflet Pastries, ... has expanded their product line of gluten-free treats ... scrumptious and as satisfying as any of their ... and never contains hydrogenated fats or oils, artificial ...
(Date:3/6/2015)... Dr. Mark Sowell recently returned from leading ... Offering programs for advanced education in the field of dentistry, ... , As a visiting faculty member of this prestigious institution, ... time he visits Spear Education to participate in a specialized ... are training only the top 10% and those willing to ...
(Date:3/5/2015)... From Oct. 5-10, Mumbai, India will serve ... . These dates include the following activities:, ... October 6: Conference Day 1, ending with a ... Day 2, ending with Local Entertainment and Dinner , ... other Materials Meetings , October 9-10: Textiles in ...
(Date:3/5/2015)... A Bakersfield, Calif. state court jury returned a verdict this ... Coleen M. Perry a total of $5.7 million for damages ... sling device, manufactured by Ethicon, Inc., a subsidiary of Johnson ... Wagstaff & Cartmell in Kansas City, Mo., was ... Freese and Tim Goss of Freese & Goss ...
Breaking Medicine News(10 mins):Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 3Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 4Health News:Plano Dentist Teaches Dentists from Around the Globe at Spear Education 2Health News:Textile Exchange Announces the 2015 Textile Sustainability Conference Dates 2Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2
... Commercial Grade Cardio Bike Created Specifically for Middle ... Fitness(R), the leading supplier and developer of interactive ... the S3 Upright Youth Bike, a virtual-reality cardio ... The S3 Youth Bike is the only commercial-grade ...
... Uses BVS 5.6 Onboard Software to Navigate the Safest, Most ... Hope, Healing and Hospital Services to the World,s PoorSUNNYVALE, Calif., ... (AWT) today announced that Mercy Ships , the leader ... services to the poor, recently used the latest version of ...
... from a life of creative writings and author,s ... Randy Patterson has spent the last three ... and extremely rare cancer called Burkitt,s Lymphoma. After ... taps, mounting financial debt, and constant worry for ...
... Corp. ("SXC" or the "Company") (NASDAQ: SXCI , ... announces that Standard and Poor,s (S&P) has added the Company ... Quarterly S&P/TSX Composite Index review. The change will be effective ... are very pleased with our inclusion on the index," said ...
... 16 Stereotaxis, Inc. (Nasdaq: STXS ) today ... Valley Bank, a member company of SVB Financial Group (Nasdaq: ... matures on March 31, 2010, the Company can borrow up ... credit, combined with our existing cash position and other financing ...
... To commemorate Brain Awareness Week, Posit Science today ... consumers are still spending their money on keeping their ... brain fitness industry to growth in the publication of ... that certain types of cognitive training yields benefits. ...
Cached Medicine News:Health News:Expresso Fitness(R) Launches First Virtual Reality Cardio Bike for Kids 2Health News:Applied Weather Technology Guides Mercy Ships With Latest BVS Marine Voyage Optimization Software 2Health News:Applied Weather Technology Guides Mercy Ships With Latest BVS Marine Voyage Optimization Software 3Health News:Applied Weather Technology Guides Mercy Ships With Latest BVS Marine Voyage Optimization Software 4Health News:Trinadgey Launches to Sci-Fi Lovers via New Online Portal Trinadgey.com 2Health News:SXC Health Solutions Added to S&P/TSX Composite Index 2Health News:Stereotaxis Extends Its Credit Facility With Silicon Valley Bank 2Health News:Stereotaxis Extends Its Credit Facility With Silicon Valley Bank 3Health News:Brain Fitness Industry Growth Driven By Science 2Health News:Brain Fitness Industry Growth Driven By Science 3
GelPort hand access laparoscopy combines the patient outcomes of minimally invasive surgery with the speed and precision of open surgery....
... Systems non-adhesive sealing method maintains ... Surgrery (HALS) procedures, allowing the ... palpate throughout. Because HALS requires ... cm, patients experience less trauma ...
... a Hand Assisted Laparoscopic Surgery (HALS) device ... hand may facilitate the procedure, and for ... in colorectal, urological and general surgical procedures. ... of pneumoperitoneum and abdominal access for the ...
... The SleepStyle 200 series offers a ... CPAP models. The design delivers therapy ... Performance features promote results in commercial ... The strongest differentiator in the SleepStyle ...
Medicine Products: